Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register

Poster: The use of fragment ion and collision cross section for confident identification from LC-ION mobility-MS metabolomics data (Waters Corporation)

7 Oct 2014
General interest

A novel and confident identification of metabolomics and lipidomics UPLC-ion mobility MS datasets
bases on fragment ion and collision cross section.


Click here to view poster

Related Links

  • Waters Corporation

 

Top content

  • New-generation ADCs redefine treatment for HER2-positive breast cancer
  • UHPLC–MS: ultra highly-petrifying literature creeps me speechless
  • How blockchain and AI are transforming data integrity in bioanalysis

Related tags

LC metabolomics MS
Previous article

Related articles

18 DEC 2012 CHROMATOGRAPHY
Direct bioanalytical sample injection with 2D LC–MS
18 JUN 2012 CHROMATOGRAPHY
Validation study of urinary metabolites as potential biomarkers for prostate cancer detection
25 MAY 2011 CHROMATOGRAPHY
Bioimaging of elements and small molecules using MS
30 JUN 2009 CHROMATOGRAPHY
Recent progress in selected reaction monitoring MS-driven plasma protein biomarker analysis
6 JUL 2020 INTERVIEWS
Metabolomics: an interview with Ann Van Eeckhaut
24 OCT 2011 CHROMATOGRAPHY
Global metabolic profiling (metabonomics/metabolomics) using dried blood spots: advantages and pitfalls
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone